Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
4
×
startups
4
×
boston blog main
boston top stories
new york blog main
new york top stories
biogen
boston
clinical trials
investing
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
vc
venture capital
89bio
abbvie
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
antisense oligonucleotide
astrazeneca
azacitidine
bain capital
benzodiazepines
beta-thalassemia
biotech ipos
blackstone group
blackstone life sciences
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cerevel therapeutics
What
research
4
×
aims
biotech
drugs
medicines
new
alzheimer’s
annual
approach
assessed
attention
awards
backed
based
billions
bio
called
cause
ceo
cities
communities
companies
conference
debuts
developing
diego
diego’s
dollars
dozens
drug
economic
epigenetic
epigenetics
epilepsy
esmo
europe
field
flagship’s
genes
genetic
Language
unset
Current search:
startups
×
research
×
" national top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More